Pharmaceutical Executive

Pharmaceutical Executive: June 2023
Volume: 43
Issue: 6

Pharmaceutical Executive: May 2023
Volume: 43
Issue: 5

Pharmaceutical Executive: April 2023
Volume: 43
Issue: 4

Pharmaceutical Executive: March 2023
Volume: 43
Issue: 3

Pharmaceutical Executive: February 2023
Volume: 43
Issue: 02

Pharmaceutical Executive: January 2023
Volume: 43
Issue: 01

Pharmaceutical Executive-12-01-2022
Volume: 42
Issue: 12

Pharmaceutical Executive-11-01-2022
Volume: 42
Issue: 11

Pharmaceutical Executive-10-01-2022 APEX Awards Program

Pharmaceutical Executive-10-01-2022
Volume: 42
Issue: 10

Pharmaceutical Executive-09-01-2022
Volume: 42
Issue: 9

Pharmaceutical Executive-08-01-2022
Volume: 42
Issue: 8

Pharmaceutical Executive-07-01-2022
Volume: 42
Issue: 7

Pharmaceutical Executive-06-01-2022
Volume: 42
Issue: 6

Pharmaceutical Executive-05-01-2022
Volume: 42
Issue: 5

Pharmaceutical Executive-04-01-2022
Volume: 42
Issue: 4

Pharmaceutical Executive-03-01-2022
Volume: 42
Issue: 3

Pharmaceutical Executive-02-01-2022
Volume: 42
Issue: 2

Pharmaceutical Executive-01-01-2022
Volume: 42
Issue: 1

Pharmaceutical Executive-12-01-2021
Volume: 41
Issue: 12

Pharmaceutical Executive-11-01-2021
Volume: 41
Issue: 11

Pharmaceutical Executive-10-01-2021
Volume: 41
Issue: 10

Pharmaceutical Executive-09-01-2021
Volume: 41
Issue: 9

Pharmaceutical Executive-08-01-2021
Volume: 41
Issue: 8

Pharmaceutical Executive-07-01-2021
Volume: 41
Issue: 7

Pharmaceutical Executive-06-01-2021
Volume: 41
Issue: 6

Pharmaceutical Executive-05-01-2021
Volume: 41
Issue: 5

Pharmaceutical Executive-04-01-2021
Volume: 41
Issue: 4

Pharmaceutical Executive-03-01-2021
Volume: 41
Issue: 3

Pharmaceutical Executive-02-01-2021
Volume: 41
Issue: 2
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
2
FDA Approves Revtorpyk for Treatment of Advanced HR-Positive, HER2-Negative Breast Cancer
3
Insilico Medicine Enters $2.5 Billion Alliance with Bora Pharmaceuticals
4
Eli Lilly to Acquire AtaiBeckley for $2.8 Billion
5
